These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8839546)

  • 1. Family history and survival of young women with invasive breast carcinoma.
    Malone KE; Daling JR; Weiss NS; McKnight B; White E; Voigt LF
    Cancer; 1996 Oct; 78(7):1417-25. PubMed ID: 8839546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of reproductive factors to mortality from breast cancer.
    Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F; Bergh J; Zack M; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing mortality among young women with second primary breast carcinoma.
    Bernstein JL; Lapinski R; Lynch C; Holford T; Thompson WD
    Cancer; 2002 Nov; 95(10):2051-8. PubMed ID: 12412157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women.
    Olson JE; Sellers TA; Anderson KE; Folsom AR
    Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childbearing and survival after breast carcinoma in young women.
    Mueller BA; Simon MS; Deapen D; Kamineni A; Malone KE; Daling JR
    Cancer; 2003 Sep; 98(6):1131-40. PubMed ID: 12973836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.
    O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW
    Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience.
    Haas JA; Schultz DJ; Peterson ME; Solin LJ
    Cancer J Sci Am; 1998; 4(5):308-15. PubMed ID: 9815295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for carcinoma in situ of the breast.
    Trentham-Dietz A; Newcomb PA; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):697-703. PubMed ID: 10919740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
    Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
    Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of family history for patients with carcinoma of the breast.
    Israeli D; Tartter PI; Brower ST; Mizrachy B; Bratton J
    J Am Coll Surg; 1994 Jul; 179(1):29-32. PubMed ID: 8019721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.